FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240715E00038
1. Date of relevant event: 10/07/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02228
4. Name of listed corporation: QuantumPharm Inc. - P 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 3,415,568,761
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Jiang
(Other names) Yide Alan
10. Name of director (Chinese):  
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1711Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box)
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 		 10,000,000         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position10,000,0000.29
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position10,000,0000.29
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position3,800,000
2305Beneficiary of a trust (other than a discretionary interest)
Long position3,800,000
2201Interest of corporation controlled by you
Long position2,400,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
ASJX Envision LLC83 Bird Street, Needham, MA 02492Jiang Yide Alan100.00Y
Long position2,400,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
YAJ 2022 Irrevocable Gift TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position3,800,000
JJX 2022 Irrevocable Gift TrustAddresses of individuals are not displayed.
5102Beneficiary of a trust (other than a discretionary interest)
Long position3,800,000
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: 方格24：行使超额配售权额外发行8,796,000股份。方格27：根据蒋一得以温书豪为受益人签订的授权书，自2024年6月13日起蒋一得无条件、无限期及不可撤销地授权及指定温书豪行使蒋一得所享有的股份及购股权附带的全部投票权。
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 15/07/2024
(dd/mm/yyyy)